1. The defendant up to C:

(a) not emulatibmeate is included as active ingredients.

1. Basic facts

A. The Plaintiff’s patented invention (hereinafter “instant patented invention”) holds the following patent rights (hereinafter “Plaintiff’s patent rights”).

1) Invention name: E-2)/Date of Claim / Patent Registration Number: F/G 27/100 / G/H 3) Claim / 8 / 4-(4-ethyl ethyl-1-Japan) of chemical formula (I) / [4-ethyl ethyl-3-(4-0-0)-N-4-ylethyl-4-phenyl of the above minister’s / [4-ethyl-4-ylethyl-4-phenyl-4] composition-specific substance of pharmaceutical product / [4-ethyl-4-ylethyl-4-phenyl-4] medicinal ethyl-4 of the above minister’s / [4-ylmethyl-4] composition-specific product / [4-ylmethyl-4-ylmethyl-4] composition-specific substance of the above minister’s / [4-ethyl-4-yl et al. (4].

A. A product license for manufacture and sale was granted as of March 21, 2013; May 31, 2013; and April 30, 2013. The principal ingredients of the Defendant’s product are the same as claims 5 inventions among the patented inventions in the instant case.